Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05412849

Radiation Field, Dose and Fractionation Related to Mandibular Complications

Is the Radiation Field, Dose and Fractionation Crucial for the Development of Mandibular Complications When Treating Malignancies in the Oropharyngeal Region?

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Lund University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Radiotherapy is inhibiting the healing capacity of the mandibular bone. Late complications as bone exposure, fracture of the jaw, osteoradionecrosis might be a consequence of this vulnerability. A factor that could be involved in the development of complications is field of radiation. There are limited number of studies investigating this relation. Retrospective analysis of a head and neck oncology register with prospectively included patients will be performed. Patients will be related to the University hospitals in Lund, Umea, Orebro, Stockholm. A thorough analysis of the medical journals in this group of patients will be performed. Included patients have been treated with combination of surgery and radiotherapy to treat malignancies in the head and neck region. At least 12 months follow up period is needed for inclusion. The scientific aim is to investigate weather the field of radiation and fractionation is crucial for developing the formentioned complications.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiotherapyRadiotherapy site, time perspective and dose

Timeline

Start date
2023-01-01
Primary completion
2025-01-01
Completion
2025-07-01
First posted
2022-06-09
Last updated
2024-05-23

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05412849. Inclusion in this directory is not an endorsement.